Rolf Müller

Active 1964–2025

Also published as
Rolf Muller
389
Papers
55,741
Citations
120
h-index
356
i10-index

Citations

Citations per year for Rolf Müller1966: 1 citations1967: 1 citations1970: 1 citations1972: 1 citations1973: 1 citations1977: 1 citations1979: 1 citations1980: 1 citations1981: 4 citations1982: 4 citations1983: 37 citations1984: 101 citations1985: 156 citations1986: 211 citations1987: 222 citations1988: 225 citations1989: 227 citations1990: 282 citations1991: 281 citations1992: 188 citations1993: 161 citations1994: 177 citations1995: 188 citations1996: 190 citations1997: 226 citations1998: 225 citations1999: 250 citations2000: 237 citations2001: 255 citations2002: 257 citations2003: 263 citations2004: 250 citations2005: 285 citations2006: 310 citations2007: 283 citations2008: 319 citations2009: 370 citations2010: 283 citations2011: 236 citations2012: 237 citations2013: 263 citations2014: 264 citations2015: 346 citations2016: 391 citations2017: 380 citations2018: 398 citations2019: 1,243 citations2020: 1,205 citations2021: 1,578 citations2022: 1,406 citations2023: 1,176 citations2024: 2,067 citations2025: 1,047 citations2026: 37 citations1968–1969: no citations, so these years are not shown1971: no citations, so this year is not shown1974–1976: no citations, so these years are not shown1978: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,341 citing papers, 25.4% of this breakdownChina: 2,490 citing papers, 11.8% of this breakdownGermany: 2,077 citing papers, 9.9% of this breakdownUnited Kingdom: 1,170 citing papers, 5.6% of this breakdownFrance: 766 citing papers, 3.6% of this breakdownIndia: 642 citing papers, 3% of this breakdownJapan: 611 citing papers, 2.9% of this breakdownItaly: 544 citing papers, 2.6% of this breakdownCanada: 525 citing papers, 2.5% of this breakdownAustralia: 444 citing papers, 2.1% of this breakdownSpain: 434 citing papers, 2.1% of this breakdownNetherlands: 427 citing papers, 2% of this breakdown
0%25.4%Other 26.5%

Fields

  • Biochemistry, Genetics and Molecular Biology42.8%
  • Medicine31.1%
  • Immunology and Microbiology6.4%
  • Agricultural and Biological Sciences4.9%
  • Computer Science2.4%
  • Neuroscience2.4%
  • Other10%

Topics

  • Microbial Natural Products and Biosynthesis5.6%
  • Genomics and Phylogenetic Studies2.3%
  • Cancer-related Molecular Pathways1.6%
  • Microbial Metabolic Engineering and Bioproduction1.4%
  • RNA and protein synthesis mechanisms1.4%
  • Plant biochemistry and biosynthesis1.2%
  • Other86.5%

Coauthors

All papers

Open in search
  1. Natural products in drug discovery: advances and opportunities

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Keith M. Godfrey, Christian W. Gruber, Jag Heer, Lukas A. Huber, Elena Ibáñez, Anake Kijjoa, Anna K. Kiss, Aiping Lü, Francisco A. Macı́as, Mark J.S. Miller, Andrei Mocan, Rolf Müller, Ferdinando Nicoletti, George Perry, Valeria Pittalà, Luca Rastrelli, Michael Ristow, Gian Luigi Russo, A. Sanches‐Silva, Daniela Schuster, Helen Sheridan, Krystyna Skalicka‐Woźniak, Léandros Skaltsounis, Eduardo Sobarzo‐Sánchez, David S. Bredt, Hermann Stuppner, Antoni Sureda, Nikolay Tzvetkov, Rosa Anna Vacca, Bharat B. Aggarwal, Maurizio Battino, Francesca Giampieri, Michaël Wink, Jean‐Luc Wolfender, Jianbo Xiao, Andy Wai Kan Yeung, Gérard Lizard, Michael Popp, Michael Heinrich, Ioana Berindan-Neagoe, Marc Stadler, Maria Daglia, Robert Verpoorte, Claudiu T. Supuran - Nature Reviews Drug Discovery 2021 cited by 5,001

  2. Towards the sustainable discovery and development of new antibiotics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Titz, Jennifer Herrmann, Timo Jaeger, Silke Alt, Thomas Hesterkamp, Mathias Winterhalter, Andrea Schiefer, Kenneth Pfarr, Achim Hoerauf, Heather Graz, Michael Graz, Mika Lindvall, Savithri Ramurthy, Anders Karlén, Maarten van Dongen, Hrvoje Petković, Andreas Keller, Frédéric Peyrane, Stefano Donadio, Laurent Fraisse, Laura J. V. Piddock, Ian H. Gilbert, Heinz E. Moser, Rolf Müller - Nature Reviews Chemistry 2021 cited by 1,155

  3. Artificial intelligence for natural product drug discovery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Willem Jespers, Olga V. Kalinina, Satria A. Kautsar, Hyun Woo Kim, Tiago Leão, Joleen Masschelein, Evan Rees, Raphael Reher, Daniel Reker, Philippe Schwaller, Marwin Segler, Michael A. Skinnider, Allison S. Walker, Egon Willighagen, Barbara Zdrazil, Nadine Ziemert, Rebecca J. M. Goss, Pierre Guyomard, Andrea Volkamer, William H. Gerwick, Hyun Uk Kim, Rolf Müller, Gilles P. van Wezel, Gerard J. P. van Westen, Anna K. H. Hirsch, Roger G. Linington, Serina L. Robinson, Marnix H. Medema - Nature Reviews Drug Discovery 2023 cited by 390

  4. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , A. James Link, Wen Liu, Mohamed A. Marahiel, Douglas A. Mitchell, Gert N. Moll, Bradley S. Moore, Rolf Müller, Satish K. Nair, Ingolf F. Nes, Gillian E. Norris, Baldomero M. Olivera, Hiroyasu Onaka, Mark L. Patchett, Joern Piel, Martin J. T. Reaney, Sylvie Rebuffat, R. Paul Ross, Hans‐Georg Sahl, Eric W. Schmidt, Michael E. Selsted, Konstantin Severinov, Ben Shen, Kaarina Sivonen, Leif Smith, Torsten Stein, Roderich D. Süßmuth, John Tagg, Gong‐Li Tang, Andrew W. Truman, John C. Vederas, Christopher T. Walsh, Jonathan D. Walton, Silke C. Wenzel, Joanne M. Willey, Wilfred A. van der Donk - Natural Product Reports 2012 cited by 2,087

  5. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2014 cited by 899

  6. Compendium of specialized metabolite biosynthetic diversity encoded in bacterial genomes

    Authors: , , , , , , - Nature Microbiology 2022 cited by 347

  7. PLSDB: advancing a comprehensive database of bacterial plasmids

    Authors: , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2021 cited by 268

  8. Fighting antibiotic resistance—strategies and (pre)clinical developments to find new antibacterials

    Authors: , , , , , , , , - EMBO Reports 2022 cited by 158

  9. Heterologous expression of bacterial natural product biosynthetic pathways

    Authors: , , , , , - Natural Product Reports 2019 cited by 243

  10. Targeting DnaN for tuberculosis therapy using novel griselimycins

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sophie Lagrange, Rolf Müller - Science 2015 cited by 313

  11. The Unique Molecular and Cellular Microenvironment of Ovarian Cancer

    Authors: , , , , , , - Frontiers in Oncology 2017 cited by 286

  12. Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds

    Authors: , , - Gene 1995 cited by 1,996

  13. antiSMASH 3.0 - a comprehensive resource for the genome mining of biosynthetic gene clusters

    Authors: , , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2015 cited by 1,909

  14. Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting

    Authors: , , , , , , , , , , - Nature Biotechnology 2012 cited by 447

  15. Biocompatible bacteria-derived vesicles show inherent antimicrobial activity

    Authors: , , , , , , , - Journal of Controlled Release 2018 cited by 130

  16. Improved broad-spectrum antibiotics against Gram-negative pathogens via darobactin biosynthetic pathway engineering

    Authors: , , , , , , , - Chemical Science 2021 cited by 78

  17. First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy

    Authors: , , , , , , , , , , , , , , - ACS Chemical Biology 2022 cited by 69

  18. Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C

    Authors: , , , , , , , , , - Cell Death and Disease 2020 cited by 142

  19. Biosynthesis of Cittilins, Unusual Ribosomally Synthesized and Post-translationally Modified Peptides from Myxococcus xanthus

    Authors: , , , , , , - ACS Chemical Biology 2020 cited by 79

  20. Rational construction of genome-reduced Burkholderiales chassis facilitates efficient heterologous production of natural products from proteobacteria

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 60

  21. Bacteria as genetically programmable producers of bioactive natural products

    Authors: , , - Nature Reviews Chemistry 2020 cited by 155

  22. ExoCET: exonuclease in vitro assembly combined with RecET recombination for highly efficient direct DNA cloning from complex genomes

    Authors: , , , , , , , , , , - Nucleic Acids Research 2017 cited by 153

  23. The Translational Machinery of Human CD4+ T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic Remodeling

    Authors: , , , , , , , , , - Cell Metabolism 2018 cited by 173

  24. Polyunsaturated fatty acid production by Yarrowia lipolytica employing designed myxobacterial PUFA synthases

    Authors: , , , , , , , - Nature Communications 2019 cited by 124